Indole alleviates nonalcoholic fatty liver disease in an ACE2 ‐dependent manner
The FASEB Journal · 2024
DOI: 10.1096/fj.202401172rr ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, 2024. Verfasst von Yuanyuan Gao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease, Angiotensin-Converting Enzyme 2, Indoles, Mice, Inbred C57BL. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: MOST | National Natural Science Foundation of China (NSFC), National Natural Science Foundation of China.
Abstract (Originalsprache)
Indole is a microbial metabolite produced by the gut microbiota through the degradation of dietary tryptophan, known for its well‐established anti‐inflammatory and antioxidant properties. In this study, we collected fecal samples from mice fed a high‐fat diet (HFD) and those on a standard diet (SD), then conducted 16S rRNA sequencing to analyze their gut microbiota. The analysis revealed distinct differences in the dominant bacterial species between the two groups, with a significant decrease in indole‐producing probiotics in the HFD mice compared to the SD group. Then we administered oral indole treatment to male C57BL/6J mice with HFD‐induced NAFLD and observed a significant improvement in hepatic steatosis and inflammation. Notably, indole alleviated the HFD‐induced decline in serum Angiotensin‐(1–7) [Ang‐(1–7)] levels and Angiotensin‐Converting Enzyme 2 (ACE2) expression. To further investigate the role of indole and ACE2 in NAFLD, we conducted experiments using ACE2 knockout (ACE2KO) mice that were also induced with HFD‐induced NAFLD and treated with indole. Interestingly, the protective effects of indole were compromised in the absence of ACE2. In HepG2 cells, indole similarly stimulated ACE2 expression and, in an ACE2‐dependent manner, reduced ROS generation, maintained mitochondrial membrane potential stability, and increased SIRT3 expression. In summary, our results highlight the formation of a biologically active gut‐liver axis between the gut microbiota and the liver through the tryptophan metabolite indole, which mitigates NAFLD in an ACE2‐dependent manner. Elevating dietary tryptophan and increasing indole levels may represent an effective approach for preventing and treating NAFLD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
ORCID-Profile: Yuanyuan Gao, Qi Chen, Songtao Yang, Jie Cao, Fangyu Li, Rui Li, Zhuoying Wu, Ying Wang, Li Yuan
Förderung
- MOST | National Natural Science Foundation of China (NSFC)
- National Natural Science Foundation of China
Zitieren
APA
Gao, Y., Chen, Q., Yang, S., Cao, J., Li, F., Li, R., Wu, Z., Wang, Y., & Yuan, L. (2024). Indole alleviates nonalcoholic fatty liver disease in an ACE2 ‐dependent manner. The FASEB Journal. https://doi.org/10.1096/fj.202401172rr
Vancouver
Gao Y, Chen Q, Yang S, Cao J, Li F, Li R, et al. Indole alleviates nonalcoholic fatty liver disease in an ACE2 ‐dependent manner. The FASEB Journal. 2024. doi:10.1096/fj.202401172rr
BibTeX
@article{Gao2024,
author = {Gao, Yuanyuan and Chen, Qi and Yang, Songtao and Cao, Jie and Li, Fangyu and Li, Rui and Wu, Zhuoying and Wang, Ying and Yuan, Li},
title = {Indole alleviates nonalcoholic fatty liver disease in an ACE2 ‐dependent manner},
journal = {The FASEB Journal},
year = {2024},
doi = {10.1096/fj.202401172rr}
}
EUVIMED